For years, shingles was viewed primarily as a painful skin and nerve condition. However, emerging research suggests the Varicella zoster virus (VZV)—the same virus behind childhood chickenpox—may influence stroke risk and cognitive decline.
The “Terrain” and Viral Reactivation
VZV remains dormant in the nervous system for life. From a functional medicine perspective, the critical question isn’t just the virus’s presence, but why it reactivates. Reactivation is often a symptom of a compromised “terrain,” driven by:
- Chronic stress and immune dysfunction.
- Persistent inflammation.
- Age-related immune decline (immunosenescence).
When the immune system loses its ability to keep latent viruses in check, the risk for complications rises. Supporting immune resilience through blood sugar balance, sleep quality, and gut health is essential for maintaining this viral latency.
The Stroke and Dementia Connection
The strongest evidence currently links shingles to an increased stroke risk in the months following reactivation. This likely stems from vascular inflammation or direct viral effects on cerebral arteries. While the link to dementia is still being investigated, the underlying mechanisms—oxidative stress and systemic inflammation—are well-known drivers of neurodegeneration.
A Proactive Approach to Aging
While some studies suggest shingles vaccines might reduce dementia risk, researchers note a “healthy vaccinee bias.” Regardless of vaccination status, the functional medicine goal remains the same: cultivating resilience.
Brain health is inseparable from immune and vascular health. Rather than waiting for symptoms, we must prioritize:
- Anti-inflammatory nutrition and movement.
- Nervous system regulation.
- Reducing toxic and metabolic burdens.
Whether or not VZV is a primary cause of cognitive decline, its reactivation serves as a vital signal that the body’s defense systems need support. Healthy aging is about building a body capable of keeping old threats at bay.